How to Better Understand the New Currencies for Access

Expand your understanding of how ongoing funding is contingent on real-world clinical performance. Master how RWE in lifecycle management involves navigating the shift toward HTA reassessments. You’ll walk away with practical tips to:

• Assist your company’s transition to using generative AI by analyzing the role of AI in evidence packages, automating economic modelling, and streamlining pCPA negotiation prep.
• Understand how HTA agencies are thinking about generative AI
• Enhance data interoperability challenges by overcoming the fragmentation of Canadian health data.
• Embed AI systems in clinical workflows to capture RWE across the lifecycle and minimize adverse events
• Optimize governance and ethics to address payer concerns regarding the reimbursement process

 Determine the strategic investments and multi-stakeholder partnerships required for you to transition from reactive data collection to a proactive, AI-enabled evidence strategy.